AdaptHealth stock plunges 16.4% after Q4 revenue beat but posts $0.76/share GAAP loss
AdaptHealth reported Q4 revenue of $846.3 million, beating analyst expectations, but posted a GAAP loss of $0.76 per share versus a $0.37 profit a year earlier. Operating margin fell to negative 8.7% from 11.4%, while adjusted EBITDA of $163.1 million missed forecasts by 14%, sparking a 16.4% stock drop.
1. Q4 Financial Results
AdaptHealth delivered Q4 revenue of $846.3 million, exceeding consensus estimates, but recorded a GAAP loss of $0.76 per share compared with a $0.37 per share profit in Q4 2024.
2. Profitability and Margin Pressures
Operating margin contracted to negative 8.7% from positive 11.4% year-over-year, while adjusted EBITDA of $163.1 million fell about 14% short of analyst forecasts, reflecting elevated costs and lower profitability.
3. Market Reaction and Implications
Shares plunged 16.4% following the report, marking one of the largest daily moves in a year and highlighting investor concern over the company’s profitability challenges despite top-line growth.